Lars C. Wallentin
Lars C. Wallentin publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, on topics such as Atrial Fibrillation Management and Outcomes, Acute Myocardial Infarction Research and Antiplatelet Therapy and Cardiovascular Diseases.
- World rank
- #41,367 of 7,710,434 ranked researchers
- Rank in Sweden
- #280 of 71,437
- Works
- 1,147
- Citations
- 118k
- Citations per work
- 103.3
What does Lars C. Wallentin research?
Lars C. Wallentin's work is mostly in Medicine (70%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences80370.0%
- Medicine80370.0%
- Everything else34430.0%
- 1Cardiology and Cardiovascular Medicine46% of their works
- 2Surgery10% of their works
- 3Radiology, Nuclear Medicine and Imaging4% of their works
- 4Epidemiology4% of their works
- 5Internal Medicine3% of their works
- 6Endocrinology, Diabetes and Metabolism3% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Imaging and Diagnostics
- Venous Thromboembolism Diagnosis and Management
- Coronary Interventions and Diagnostics
- Lipoproteins and Cardiovascular Health
- GDF15 and Related Biomarkers
Which keywords describe Lars C. Wallentin's research?
The keywords of their largest research topics: Guidelines, Myocardial Infarction, Cardiovascular Disease, Percutaneous Coronary Intervention, Anticoagulant Therapy, Atrial Fibrillation, Acute Coronary Syndromes and ST-Segment Elevation.
- TGF-ß Superfamily
- Statins
- Venous Thromboembolism
- Coronary Stents
- Coronary Artery Disease
- Clopidogrel
- ST-Segment Elevation
- Atrial Fibrillation
- Percutaneous Coronary Intervention
- Myocardial Infarction
- Guidelines
- Cardiovascular Disease
- Anticoagulant Therapy
- Acute Coronary Syndromes
- Aspirin
- Cardiac Imaging
- Antithrombotic Therapy
- Myocardial Revascularization
- Cholesterol-lowering
- Growth-Differentiation Factor-15
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Guidelines6942 topics
- Myocardial Infarction4582 topics
- Cardiovascular Disease3932 topics
- Percutaneous Coronary Intervention3762 topics
- Anticoagulant Therapy3571 topic
- Atrial Fibrillation3571 topic
- Acute Coronary Syndromes3371 topic
- ST-Segment Elevation3371 topic
- Aspirin2731 topic
- Clopidogrel2731 topic
- Cardiac Imaging1211 topic
- Coronary Artery Disease1211 topic
- Antithrombotic Therapy1031 topic
- Coronary Stents1031 topic
- Myocardial Revascularization1031 topic
- Venous Thromboembolism1031 topic
- Cholesterol-lowering931 topic
- Statins931 topic
- Growth-Differentiation Factor-15561 topic
- TGF-ß Superfamily561 topic
Where does Lars C. Wallentin work?
Lars C. Wallentin's main affiliation in the publication record is Uppsala University, Sweden.
How many publications and citations does Lars C. Wallentin have?
OpenAlex counts 1,147 works and 118,485 citations for Lars C. Wallentin, an h-index of 148, ranking #41,367 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lars C. Wallentin. Posts are plain text and can be reported.